Masters CL, Bateman R, Blennow K, Rowe CC, Sperling RA, Cummings JL. Alzheimer’s disease. Nat Rev Dis Primers. 2015;1(1):1–18.
Alzheimer’s Association. 2025 Alzheimer’s disease facts and figures. Alzheim Dementia. 2025;21(5):e70235. Published online 2025 Apr 29. https://doi.org/10.1002/alz.70235.
Zhang J, Zhang Y, Wang J, Xia Y, Zhang J, Chen L. Recent advances in Alzheimer’s disease: mechanisms, clinical trials and new drug development strategies. Signal Transduct Target Ther. 2024;9(1):211.
Article CAS PubMed PubMed Central Google Scholar
Jack CR, Bennett DA, Blennow K, Carrillo MC, Dunn B, Hyman BT, et al. Revised criteria for diagnosis and staging of Alzheimer’s disease. Alzheim Dementia. 2024;20(7):1399–415. https://doi.org/10.1002/alz.14587.
Tan CC, Yu JT, Tan L. Biomarkers for preclinical Alzheimer’s disease. J Alzheimers Dis. 2014;42(4):1051–69.
Article CAS PubMed Google Scholar
Chetty CA, Bhardwaj H, Kumar GP, Devanand T, Sekhar CA, Aktürk T, et al. EEG biomarkers in Alzheimer’s and prodromal Alzheimer’s: a comprehensive analysis of spectral and connectivity features. Alzheim Res Therapy. 2024;16(1):236.
Jack CR Jr, Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, et al. NIA-AA research framework: toward a biological definition of Alzheimer’s disease. Alzheim Dementia. 2018;14(4):535–62.
Cedazo-Minguez A, Winblad B. Biomarkers for Alzheimer’s disease and other forms of dementia: clinical needs, limitations and future aspects. Exp Gerontol. 2010;45(1):5–14.
Article CAS PubMed Google Scholar
Rossini PM, Di Iorio R, Vecchio F, Anfossi M, Babiloni C, Bozzali M, et al. Early diagnosis of Alzheimer’s disease: the role of biomarkers including advanced EEG signal analysis. Report from the IFCN-sponsored panel of experts. Clinical Neurophysiol. 2020;131(6):1287–1310.
Romanella S, Roe D, Tatti E, Cappon D, Paciorek R, Testani E, et al. The sleep side of aging and Alzheimer’s disease. Sleep Med. 2021;77:209–25.
Article CAS PubMed Google Scholar
Mander BA, Marks SM, Vogel JW, Rao V, Lu B, Saletin JM, et al. \(\beta \)-amyloid disrupts human NREM slow waves and related hippocampus-dependent memory consolidation. Nat Neurosci. 2015;18(7):1051–7.
Article CAS PubMed PubMed Central Google Scholar
Mander BA, Winer JR, Jagust WJ, Walker MP. Sleep: A Novel Mechanistic Pathway, Biomarker, and Treatment Target in the Pathology of Alzheimer’s Disease? Trends Neurosci. 2016;39(8):552–66. https://doi.org/10.1016/j.tins.2016.05.002.
Article CAS PubMed PubMed Central Google Scholar
Petit D, Gagnon JF, Fantini ML, Ferini-Strambi L, Montplaisir J. Sleep and quantitative EEG in neurodegenerative disorders. J Psychosom Res. 2004;56(5):487–96.
Vickers JC, Dickson TC, Adlard PA, Saunders HL, King CE, McCormack G. The cause of neuronal degeneration in Alzheimer’s disease. Prog Neurobiol. 2000;60(2):139–65.
Article CAS PubMed Google Scholar
Verret L, Mann EO, Hang GB. Inhibitory interneuron deficit links altered network activity and cognitive dysfunction in Alzheimer model. Cell. 2012;149(3):708–21.
Article CAS PubMed PubMed Central Google Scholar
Ghorbanian P, Devilbiss DM, Hess T, Bernstein A, Simon AJ, Ashrafiuon H. Exploration of EEG features of Alzheimer’s disease using continuous wavelet transform. Med Biol Eng Comput. 2015;53(9):843–55.
Jeong J. EEG dynamics in patients with Alzheimer’s disease. Clin Neurophysiol. 2004;115(7):1490–505.
Holth JK, Fritschi SK, Wang C, Pedersen NP, Cirrito JR, Mahan TE, et al. The sleep-wake cycle regulates brain interstitial fluid tau in mice and CSF tau in humans. Science. 2019;363(6429):880–4.
Article CAS PubMed PubMed Central Google Scholar
Lucey BP, McCullough A, Landsness EC, Toedebusch CD, McLeland JS, Zaza AM, et al. Reduced non–rapid eye movement sleep is associated with tau pathology in early Alzheimer’s disease. Sci Transl Med. 2019;11(474):eaau6550. Erratum in: Sci Transl Med. (2020) 8;12(525).
Buzsáki G. Rhythms of the brain. Oxford University Press; 2012.
Thakor NV, Tong S. Advances in quantitative electroencephalogram analysis methods. Annual Rev Biomed Eng. 2004;6:453–495. PMID: 15255777. https://doi.org/10.1146/annurev.bioeng.5.040202.121601.
Mander BA, Winer JR, Walker MP. Sleep: a novel mechanistic pathway, biomarker, and treatment target in the pathology of Alzheimer’s disease? Trends Neurosci. 2015;38(8):527–35.
Abásolo D, Hornero R, Espino P, Álvarez D, Poza J. Entropy analysis of the EEG background activity in Alzheimer’s disease patients. Physiol Measurem. 2006;27(3):241–253. Epub 2006 Jan 13, PMID: 16462011. https://doi.org/10.1088/0967-3334/27/3/003.
Azami H, Moguilner S, Penagos H, Sarkis RA, Arnold SE, Gomperts SN, et al. EEG entropy in REM sleep as a physiologic biomarker in early clinical stages of Alzheimer’s disease. J Alzheim Dis. 2023;91(4):1557–1572. PMID: 36641682; PMCID: PMC10039707. https://doi.org/10.3233/JAD-221152.
Gallego-Viñarás L, Michela-Gaeta A, Pinol-Ripoll G, Barbé F, Olmos PM, Muñoz-Barrutia A. Calibration Methods for Alzheimer Disease Detection. In: 2024 IEEE 34th International Workshop on Machine Learning for Signal Processing (MLSP). IEEE; 2024. p. 1–6.
Abásolo D, Hornero R, Gómez C, García M, López M. Analysis of EEG background activity in Alzheimer’s disease patients with Lempel-Ziv complexity and central tendency measure. Med Eng Phys. 2006;28(4):315–22.
Cassani R, Estarellas M, San-Martin R. Electroencephalographic biomarkers of Alzheimer’s disease: A review. NeuroImage: Clinical. 2018;19:518–534.
Babiloni C, Blinowska K, Bonanni L, Cichocki A, De Haan W, Del Percio C, et al. What electrophysiology tells us about Alzheimer’s disease: a window into the synchronization and connectivity of brain neurons. Neurobiol Aging. 2020;85:58–73.
Roy Y, Banville H, Albuquerque I, Gramfort A, Falk TH, Faubert J. Deep learning-based electroencephalography analysis: a systematic review. J Neural Eng. 2019;16(5):051001. https://doi.org/10.1088/1741-2552/ab260c.
Bzdok D, Altman N, Krzywinski M. Statistics versus machine learning. Nat Methods. 2018;15(4):233–4.
Article CAS PubMed PubMed Central Google Scholar
Gemein LA, Schirrmeister RT, Chrabąszcz P, Wilson D, Boedecker J, Schulze-Bonhage A, et al. Machine-learning-based diagnostics of EEG pathology. Neuroimage. 2020;220:117021.
Goldstein CA, Berry RB, Kent DT, Kristo DA, Seixas AA, Redline S, et al. Artificial intelligence in sleep medicine: background and implications for clinicians. J Clin Sleep Med. 2020;16(4):609–18.
Article PubMed PubMed Central Google Scholar
Al-Nuaimi AH, Blūma M, Al-Juboori SS, Eke CS, Jammeh E, Sun L, et al. Robust EEG based biomarkers to detect Alzheimer’s disease. Brain Sci. 2021;11(8):1026.
Article CAS PubMed PubMed Central Google Scholar
McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheim Dementia J Alzheim Assoc. 2011;7(3):263–9. https://doi.org/10.1016/j.jalz.2011.03.005.
Lobo A, Saz P, Marcos G, et al. Revalidación y normalización del mini-examen cognoscitivo (primera version en castellano del mini-mental status examination) en la población general geriátrica. Med Clin. 1999;112:767–74. https://doi.org/10.1016/S0025-7753(05)70654-4.
Tombaugh TN, McIntyre NJ. The Mini-Mental State Examination: A Comprehensive Review. J Am Geriatr Soc. 1992;40:922–35.
Article CAS PubMed Google Scholar
Liguori C, Chiaravalloti A, Izzi F, Nuccetelli M, Bernardini S, Schillaci O, et al. Sleep apnoeas may represent a reversible risk factor for amyloid-\(\beta \) pathology. Brain. 2017;140(12):e75–e75.
Ortega RL, Dakterzada F, Arias A, Blasco E, Naudí A, Garcia FP, et al. Usefulness of CSF biomarkers in predicting the progression of Amnesic and nonamnesic mild cognitive impairment to Alzheimer’s disease. Curr Aging Sci. 2019;12:35–42. https://doi.org/10.2174/1874609812666190112095430.
Article CAS PubMed Google Scholar
Targa A, Dakterzada F, Benítez I, López R, Pujol M, Dalmases M, et al. Decrease in sleep depth is associated with higher cerebrospinal fluid neurofilament light levels in patients with Alzheimer’s disease. Sleep. 2021;44(2):zsaa147. PMID: 32766837. https://doi.org/10.1093/sleep/zsaa147.
Dhiman K, Villemagne VL, Fowler C, Bourgeat P, Li QX, Collins S, et al. Cerebrospinal Fluid Neurofilament Light Predicts Risk of Dementia Onset in Cognitively Healthy Individuals and Rate of Cognitive Decline in Mild Cognitive Impairment: A Prospective Longitudinal Study. Biomedicines. 2022;10(5):1045. https://doi.org/10.3390/biomedicines10051045.
Comments (0)